MaMaLoc: Magnetic Marker Localisation for non-palpable breast lesions. A Feasibility Study.

Completed

• Conditions: breast cancer; breast carcinoma; 10006291; 10006295

• Registration Number: NL-OMON42528
• Lead Sponsor: ederlands Kanker Instituut

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2016-08-09
• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 15

Inclusion Criteria

* Unifocal, non-palpable breast lesion
* Treated with breast sparing surgery
* Using radio-active seed localisation (RSL)
* Age > 18 years.

Exclusion Criteria

* Treated with neo-adjuvant chemotherapy
* Planned MRI in the period between marker placement and surgery
* Tumor depth >4cm

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Identification rate (IR) of the magnetic marker relative to the total amount of<br /><br>included subjects (percentage).</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable. </p><br>